PMID- 25479255 OWN - NLM STAT- MEDLINE DCOM- 20160425 LR - 20181113 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 9 IP - 12 DP - 2014 TI - Effects of maternal LPS exposure during pregnancy on metabolic phenotypes in female offspring. PG - e114780 LID - 10.1371/journal.pone.0114780 [doi] LID - e114780 AB - It is increasingly recognized that intra-uterine growth restriction (IUGR) is associated with an increased risk of metabolic disorders in late life. Previous studies showed that mice exposed to LPS in late gestation induced fetal IUGR. The present study investigated the effects of maternal LPS exposure during pregnancy on metabolic phenotypes in female adult offspring. Pregnant mice were intraperitoneally injected with LPS (50 microg/kg) daily from gestational day (GD)15 to GD17. After lactation, female pups were fed with standard-chow diets (SD) or high-fat diets (HFD). Glucose tolerance test (GTT) and insulin tolerance test (ITT) were assessed 8 and 12 weeks after diet intervention. Hepatic triglyceride content was examined 12 weeks after diet intervention. As expected, maternal LPS exposure during pregnancy resulted in fetal IUGR. Although there was an increasing trend on fat mass in female offspring whose dams were exposed to LPS during pregnancy, maternal LPS exposure during pregnancy did not elevate the levels of fasting blood glucose and serum insulin and hepatic triglyceride content in female adult offspring. Moreover, maternal LPS exposure during pregnancy did not alter insulin sensitivity in adipose tissue and liver in female adult offspring. Further analysis showed that maternal LPS exposure during pregnancy did not exacerbate HFD-induced glucose tolerance and insulin resistance in female adult offspring. In addition, maternal LPS exposure during pregnancy did not aggravate HFD-induced elevation of hepatic triglyceride content in female adult offspring. In conclusion, LPS-induced IUGR does not alter metabolic phenotypes in adulthood. FAU - Liu, Xiao-Jing AU - Liu XJ AD - Department of Toxicology, Anhui Medical University, Hefei, China; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Anhui Medical University, Hefei, China; First Affiliated Hospital, Anhui Medical University, Hefei, China. FAU - Wang, Bi-Wei AU - Wang BW AD - Department of Toxicology, Anhui Medical University, Hefei, China. FAU - Zhao, Mei AU - Zhao M AD - Anhui Provincial Key Laboratory of Population Health & Aristogenics, Anhui Medical University, Hefei, China. FAU - Zhang, Cheng AU - Zhang C AD - Department of Toxicology, Anhui Medical University, Hefei, China. FAU - Chen, Yuan-Hua AU - Chen YH AD - Department of Toxicology, Anhui Medical University, Hefei, China; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Anhui Medical University, Hefei, China. FAU - Hu, Chun-Qiu AU - Hu CQ AD - Department of Toxicology, Anhui Medical University, Hefei, China. FAU - Zhao, Hui AU - Zhao H AD - Second Affiliated Hospital, Anhui Medical University, Hefei, China. FAU - Wang, Hua AU - Wang H AD - Department of Toxicology, Anhui Medical University, Hefei, China; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Anhui Medical University, Hefei, China. FAU - Chen, Xi AU - Chen X AD - First Affiliated Hospital, Anhui Medical University, Hefei, China. FAU - Tao, Fang-Biao AU - Tao FB AD - Anhui Provincial Key Laboratory of Population Health & Aristogenics, Anhui Medical University, Hefei, China. FAU - Xu, De-Xiang AU - Xu DX AD - Department of Toxicology, Anhui Medical University, Hefei, China; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Anhui Medical University, Hefei, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20141205 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Insulin) RN - 0 (Lipopolysaccharides) RN - 0 (Triglycerides) SB - IM MH - Adipose Tissue/metabolism MH - Animals MH - Body Weight MH - Diet, High-Fat/adverse effects MH - Female MH - Fetal Growth Retardation/*metabolism MH - Insulin/blood/metabolism MH - *Insulin Resistance MH - Lipid Metabolism MH - Lipopolysaccharides/*toxicity MH - Liver/metabolism/pathology MH - Male MH - *Maternal Exposure MH - Metabolic Diseases/etiology/metabolism MH - Mice, Inbred ICR MH - Obesity/metabolism MH - Pregnancy MH - Prenatal Exposure Delayed Effects MH - Triglycerides/metabolism PMC - PMC4257726 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2014/12/06 06:00 MHDA- 2016/04/26 06:00 PMCR- 2014/12/05 CRDT- 2014/12/06 06:00 PHST- 2014/08/08 00:00 [received] PHST- 2014/11/13 00:00 [accepted] PHST- 2014/12/06 06:00 [entrez] PHST- 2014/12/06 06:00 [pubmed] PHST- 2016/04/26 06:00 [medline] PHST- 2014/12/05 00:00 [pmc-release] AID - PONE-D-14-35819 [pii] AID - 10.1371/journal.pone.0114780 [doi] PST - epublish SO - PLoS One. 2014 Dec 5;9(12):e114780. doi: 10.1371/journal.pone.0114780. eCollection 2014.